Osama El Razaky had completed MD Pediatric at age of 32 years from Tanta Universty .He had postdoctoral studies in cardiac deformation.He is a head of Egyptian Pediatric Cardiology Association and a member of Egyptian universities promotion committee(Professor of Paediatrics').He now acting as a profesior of Pediatric (Cardiology Unit ) in Tanta Uneversity.He has published 20 papers in international journal and has been serving as a Reviewer for Acta Paediatric.He was a supervisior of 100 MS and 25 MD thesis in Pediatrics.He working as echographer in Pediatrics since 25 years.His main interst in TDI,STI and 3D Strain.

Dr. Jayasri Nanduri currently works as Professorin the Institute for Integrative Physiology and Center for Systems Biology of O2sensing, Department of Medicine,The University of Chicago.Her major area of research is focused on investigating the role of hypoxia-inducible factors (HIFs) and redox state in cellular and systemic responses to IH in cell culture and rodent models.She is an author on 65 peer reviewed papers and a manuscript reviewer for several journals.

Dr. Sriram Seshadri is a trained endocrinologist with doctorate in Male Reproductive Physiology. His main research interest includes metabolic disorder, liver inflammation, gut microbiota modulation and Cancer therapeutics. He has published more than 80 research papers and 15 book chapters. He is a renowned expert in the field of Bacteriocins and Gut microbiota and he is one of the International Grant Reviewer for Czech Research Foundation, Czech Republic. He is Recipient of many awards and recognitions for his research work in the field of gut microbiota and metabolic disorder.

Dr Alan J. Stewart is a Senior Lecturer in Molecular Medicine at the University of St Andrews. His research is focused upon how metal ions are handled in the body and the roles they play in regulating medically/physiologically relevant processes. Collectively, it provides detailed and reliable data relating to the transport and speciation of metal ions (particularly Zn2+) in the circulation and new insights into their cellular functions and role in disease states. To date his work has attracted grant funding from UK Research Councils (Biological and Biotechnological Sciences Research Council (BBSRC)), British Heart Foundation, Fight for Sight and The Leverhulme Trust. He has published >70 peer-reviewed publications, many in world class and field-leading journals. He is currently a member of the BBSRC Pool of Experts and sits on the Editorial Boards of the journals, Scientific Reports and BioMetals.

Currently, Professor Wickramasinghe is the Professor of Digital Health and the Deputy Director of the Iverson Health Innovation Research Institute at Swinburne University of Technology and inaugural Professor – Director Health Informatics Management at Epworth HealthCare. She also holds honorary research professor positions at the Peter MacCallum Cancer Centre and Northern Health. After completing 5 degrees at the University of Melbourne, she was awarded a full scholarship to complete PhD studies at Case Western Reserve University, Cleveland, OH, USA and later she was sponsored to complete executive education at Harvard Business School, Harvard University, Cambridge, MA, USA in Value based HealthCare. For over 20 years, Professor Wickramasinghe has been actively, researching and teaching within the health informatics/digital health domain in US, Germany and Australia with a particular focus on designing, developing and deploying suitable models, strategies and techniques grounded in various management principles to facilitate the implementation and adoption of technology solutions to effect superior, value?based patient centric care delivery. Professor Wickramasinghe collaborates with leading scholars at various premier healthcare organizations and universities throughout Australasia, US and Europe and is well published with more than 400 referred scholarly articles, more than 15 books, numerous book chapters, an encyclopaedia and a well established funded research track record securing over $25M in funding from grants in US, Australia, Germany and China as a chief investigator.

Dr. Chih-Hao Wang received his PhD degree in Taiwan and finished the postdoctoral training at Joslin Diabetes Center, Harvard Medical School, Boston, USA. Dr. Wang is currently an assistant professor in Graduate Institute of Biomedical Sciences at China Medical University, Taichung, Taiwan. His research focuses on using pharmacological and genetic approaches to investigate the underlying mechanisms of brown fat activation and/or white fat browning. He will apply those basic scientific findings to regulate whole-body energy metabolism and to translate into new clinical treatments for human obesity, diabetes and metabolic disorders.

Dr. Prawej Ansari received his Ph.D. degree in Pharmacology based on Diabetes research from the School of Biomedical Sciences, Ulster University, UK. He has worked as a Scientist at Randox Laboratories Ltd., Antrim, UK. He has published more than 40 journal articles in highly ranked peer-reviewed journals and has served as a reviewer and editorial board member of internationally reputed peer-reviewed journals. To date, he has reviewed more than 100 articles. Dr. Ansari joined the Department of Pharmacy, Independent University, Bangladesh, in February 2021 as an Assistant Professor. His research focuses on the isolation and characterization of phytochemicals with insulin-releasing and glucose-lowering effects for the treatment of diabetes.